Bradley Morrison
@bradleymorrison.bsky.social
Heading up solid tumor oncology drug discovery team #Anviron #her2 #tnbc #mbc #pdac #dpagt1 #fuckcancer
"Having a large following opens up all sorts of possibilities for deception; not only will your followers worship you, they will defend you from your enemies and will voluntarily take on the work of enticing others to join your fledgling cult." -Robert Green, 48 Laws of Power (2000). Is he wrong?
April 16, 2025 at 1:53 AM
"Having a large following opens up all sorts of possibilities for deception; not only will your followers worship you, they will defend you from your enemies and will voluntarily take on the work of enticing others to join your fledgling cult." -Robert Green, 48 Laws of Power (2000). Is he wrong?
Reposted by Bradley Morrison
This is horrible to post, but I may as well post it. We are essentially shutting down research operations in my group, which is focused on treatments for pediatric brain cancer. I’m a well funded investigator, and there’s no choice. Science can’t function without the stability of NIH
March 15, 2025 at 5:32 PM
This is horrible to post, but I may as well post it. We are essentially shutting down research operations in my group, which is focused on treatments for pediatric brain cancer. I’m a well funded investigator, and there’s no choice. Science can’t function without the stability of NIH
Don’t let the Swamp King kill America’s drug discovery engine.
80% of pancreatic cancer research comes from the federal government—funding that’s now at risk. Don’t let progress stop. 🚫💜
Tell Congress: Protect and increase research funding NOW! Take two minutes to message your members of Congress and share why this matters to you. p2a.co/PDtC4d7
Tell Congress: Protect and increase research funding NOW! Take two minutes to message your members of Congress and share why this matters to you. p2a.co/PDtC4d7
February 26, 2025 at 2:47 AM
Don’t let the Swamp King kill America’s drug discovery engine.
The #WordOfTheDay is Schadenfreude. @dictionarycom.bsky.social
February 24, 2025 at 5:13 PM
The #WordOfTheDay is Schadenfreude. @dictionarycom.bsky.social
Reposted by Bradley Morrison
📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer.
🔓https://pubmed.ncbi.nlm.nih.gov/39908010/
@drtimothyerick.bsky.social @nlinmd.bsky.social
@stolaney1.bsky.social
🔓https://pubmed.ncbi.nlm.nih.gov/39908010/
@drtimothyerick.bsky.social @nlinmd.bsky.social
@stolaney1.bsky.social
February 7, 2025 at 7:40 PM
📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer.
🔓https://pubmed.ncbi.nlm.nih.gov/39908010/
@drtimothyerick.bsky.social @nlinmd.bsky.social
@stolaney1.bsky.social
🔓https://pubmed.ncbi.nlm.nih.gov/39908010/
@drtimothyerick.bsky.social @nlinmd.bsky.social
@stolaney1.bsky.social
Reposted by Bradley Morrison
#Oncotarget reported (Han 2015) breast tumors were reduced by #trastuzumab when combined w/ DPAGT1 inhibitors, even in #Her2 negative cancers. @anviron.bsky.social confirmed this paradox, DPAGT1 inhibitor, ANV221, upregulated Her2 in #TNBC, opening door to potent, targeted TNBC therapeutics.
November 27, 2024 at 4:46 PM
#Oncotarget reported (Han 2015) breast tumors were reduced by #trastuzumab when combined w/ DPAGT1 inhibitors, even in #Her2 negative cancers. @anviron.bsky.social confirmed this paradox, DPAGT1 inhibitor, ANV221, upregulated Her2 in #TNBC, opening door to potent, targeted TNBC therapeutics.
Developing targeted medicines to treat advanced, metastatic, drug resistant, TNBC, Her2-positive breast, and pancreatic cancers.
November 18, 2024 at 6:47 PM
Developing targeted medicines to treat advanced, metastatic, drug resistant, TNBC, Her2-positive breast, and pancreatic cancers.